Apollo Hospitals Gains 2.45%: 4 Key Factors Driving the Week’s Momentum

Monday, 13 April: Golden Cross Sparks Bullish Sentiment

On 13 April, Apollo Hospitals formed a Golden Cross, a key technical indicator where the 50-day moving average crossed above the 200-day moving average. This event is widely regarded as a bullish signal, suggesting a potential sustained upward trend. The stock closed at Rs.7,515.25, marginally up by 0.01%, while the Sensex declined 0.76% to 34,738.75. This divergence highlighted Apollo’s relative strength amid a broader market pullback.

The Golden Cross was supported by bullish daily and weekly moving averages, positive weekly MACD, and expanding Bollinger Bands, signalling strengthening momentum. However, some monthly indicators remained mildly bearish, advising cautious optimism. Apollo’s long-term returns remain impressive, with a 10.50% gain over the past year versus the Sensex’s 2.25%, reinforcing the stock’s resilience.

Monday, 13 April: Valuation Adjusts to Fair Amid Strong Fundamentals

Also on 13 April, Apollo’s valuation grade shifted from attractive to fair, reflecting a recalibration of market pricing. The stock traded at a P/E ratio of 59.58 and a P/BV of 11.90, indicating a premium but reasonable valuation relative to peers. Enterprise value multiples such as EV/EBITDA at 32.05 and EV/EBIT at 42.42 further underscored this balanced pricing.

Despite the valuation adjustment, Apollo’s operational metrics remained robust. Return on capital employed stood at 17.91%, and return on equity at 18.39%, signalling efficient capital utilisation. The PEG ratio of 1.54 suggested earnings growth expectations were fairly priced in. These fundamentals support the stock’s premium valuation and justify investor confidence.

Tuesday, 14 April: MarketsMOJO Upgrades Rating to Buy

On 13 April, coinciding with the Golden Cross and valuation update, MarketsMOJO upgraded Apollo Hospitals’ investment rating from Hold to Buy. This upgrade reflected improvements across quality, valuation, financial trends, and technical indicators. The company’s strong operational performance, including nine consecutive quarters of positive results and a quarterly net sales peak of ₹6,477.40 crores, underpinned this positive reassessment.

Financial discipline was evident with a low debt-to-EBITDA ratio of 2.40 times and a robust operating profit margin of 39.35%. The stock’s PEG ratio of 1.54 and dividend yield of 0.27% aligned with a growth-focused reinvestment strategy. Compared to peers like Max Healthcare, Apollo’s valuation and fundamentals presented a more balanced investment profile within the hospital sector.

Thursday, 15 April: Technical Momentum Turns Bullish Despite Minor Dip

On 15 April, Apollo Hospitals’ technical momentum shifted decisively to bullish, despite a slight intraday dip. The stock closed at Rs.7,646.40, up 1.75% from the previous close, while the Sensex gained 1.89%. Daily moving averages turned bullish, and weekly MACD and Bollinger Bands supported the positive trend. However, monthly MACD and KST indicators remained mildly bearish, suggesting the longer-term trend was still consolidating.

The Relative Strength Index hovered in neutral territory, indicating no immediate overbought conditions. On-Balance Volume showed mild bullishness on the monthly scale, hinting at institutional accumulation. Apollo’s price remained comfortably above its 52-week low of Rs.6,017.95, with room to approach its 52-week high of Rs.8,099.00.

Friday, 16 April: Profit Taking Causes Slight Pullback

On 16 April, the stock experienced a minor correction, closing at Rs.7,555.95, down 1.18%. This dip occurred despite the Sensex rising 0.26% to 35,485.91, reflecting some profit-taking after the prior day’s gains. Volume increased to 12,308 shares, indicating active trading. The pullback did not alter the overall bullish technical stance, as daily moving averages remained supportive and weekly momentum indicators stayed positive.

Friday, 17 April: Strong Close Caps Off the Week

On the final trading day of the week, Apollo Hospitals rebounded strongly, closing at Rs.7,699.05, up 1.89%. The Sensex also advanced 0.94% to 35,820.15. This gain marked the week’s high for the stock and capped a 2.45% weekly increase. The positive close reinforced the bullish technical momentum and reflected sustained investor confidence following the earlier upgrade and valuation adjustments.

Key Takeaways

Positive Signals: The Golden Cross formation and MarketsMOJO upgrade to Buy highlight a strong technical and fundamental backdrop. Apollo’s consistent operational performance, including high ROCE and ROE, supports its premium valuation. The stock’s outperformance relative to the Sensex over multiple timeframes underscores its resilience and leadership in the hospital sector.

Cautionary Notes: Some monthly technical indicators remain mildly bearish, suggesting the longer-term trend is still consolidating. The elevated P/E and P/BV ratios imply limited room for valuation expansion, requiring sustained earnings growth to justify current prices. The minor midweek pullback reflects normal profit-taking amid volatile market conditions.

Conclusion

Apollo Hospitals Enterprise Ltd. demonstrated a solid week marked by a 2.45% gain, slightly outperforming the Sensex. The formation of a Golden Cross and an upgrade to a Buy rating by MarketsMOJO signal renewed bullish momentum supported by strong fundamentals and operational excellence. While some technical indicators advise caution on the longer-term horizon, the stock’s robust returns and sector leadership position it well for continued performance. Investors should monitor evolving monthly technical trends and broader market conditions to gauge sustained momentum. Overall, Apollo Hospitals remains a compelling large-cap healthcare stock with improving technicals and a strong growth trajectory.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today